Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureGiulia Morsica, Sara Diotallevi, Sabrina Bagaglio, Costanza Bertoni, Romina Salpini, Stefano D'Anna, Michela Sampaolo, Caterina Uberti-Foppa, Nicola Gianotti
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
10.1016/j.jhep.2019.03.034 · 2019
Very low prevalence and no clinical significance of occult hepatitis B in a cohort of HIV-infected patients with isolated anti-HBc seropositivity: the BHOI study
10.1310/hct0905-337 · 2008
Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV cohort study
10.1007/bf01584356 · 1998
Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients
10.1089/aid.2005.21.922 · 2005
Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women
10.1086/520989 · 2007
Incidence of transaminitis among HIV-infected patients with occult hepatitis B
10.1016/j.jcv.2008.03.030 · 2008
Longitudinal evaluation of occult hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption
10.1007/s15010-011-0093-9 · 2011
Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV
10.1016/s2352-3018(19)30342-x · 2020
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment
10.1016/j.ymeth.2021.05.011 · 2022
In the setting of HIV-infection, HBV-reactivation is revealed by highly sensitive assays in a conspicuous fraction of anti-HBc-positive/HBsAg-negative patients switching to tenofovir-sparing therapy
2022
Long-term TDF-inclusive ART and progressive rates of HBsAg loss in HIV-HBV coinfection—lessons for functional HBV cure?
10.1097/qai.0000000000002386 · 2020
Hepatitis B infection or reactivation after switch to 2-drug antiretroviral therapy: a case series, literature review, and management discussion
10.1097/qai.0000000000003239 · 2023
Hepatitis B reactivation in persons with HIV with positive hepatitis B core antibody after switching to antiretroviral therapy without hepatitis B activity
10.1093/ofid/ofad500.057 · 2023
Hepatitis B virus reactivation after switch to cabotegravir/rilpivirine in patient with low hepatitis B surface antibody
10.3201/eid3008.240019 · 2024
No additional external references are available.